Interleukin-1β (IL-1β) is a major inflammatory cytokine that has diverse effects on the immune system and is considered to be relevant to cancer development, owing to high levels of serum IL-1β [18,19] and elevated gene expression [20,21] in cancer patients. This evidence concerns the gene IL1B and cancer.